Douleur Therapeutics Inc

Viking Therapeutics, Inc. is a biotechnology company based in San Diego, CA, focused on developing novel therapeutics for patients with metabolic and endocrine disorders. Their pipeline includes several drug candidates targeting conditions such as obesity, non-alcoholic steatohepatitis (NASH), and rare diseases like X-linked adrenoleukodystrophy (X-ALD). The company's key candidates include VK2735 for obesity disorders, VK2809 for NASH, and VK5211 aimed at hip fracture muscle wasting. Viking Therapeutics is committed to advancing innovative treatments that promise to improve patient outcomes in metabolic health. Generated from the website

BTS Research is a San Diego-based Contract Research Organization (CRO) that has been providing GLP and Non-GLP biological services to clients in the pharmaceutical, biopharmaceutical, biotech, academic research, medical device, and related industries since 2001. With a focus on delivering unparalleled advice and pre-clinical support, BTS Research offers a wide range of in vitro and in vivo platforms, including dozens of assays and animal models, to investigate biologics, inflammation, cancer, and metabolic diseases. Committed to advancing science in a quick and compliant manner, BTS Research prides itself on its uncompromised quality of science and animal care, ensuring regulatory compliance and adherence to the highest standards. With expertise in areas such as in vitro services, pharmacology services, toxicology services, investigational new drug processes, disease models, medical devices, custom services, and vivarium space, BTS Research is a trusted partner for discovery through IND, providing confidential and trustworthy collaborations based on trust, transparency, and fact-finding research.Generated from the website